低正常甲状腺功能与美国成人晚期纤维化相关
该研究在美国普通人群中检验低正常甲状腺功能及亚临床甲状腺功能减退与晚期纤维化的关联,以将既往活检证实的非酒精性脂肪性肝病中剂量依赖性关联推广至所有种族;原文未报告具体样本量、效应值及结论方向。
要点
- 低正常甲状腺功能定义为促甲状腺激素在甲状腺功能正常参考范围内处于较高水平。
- 作者既往报告活检证实的非酒精性脂肪性肝病晚期纤维化与促甲状腺激素水平呈剂量依赖性关联。
- 本研究旨在美国普通人群中检验该关联并推广至所有种族。
核心结论
- 原文未报告本研究的具体结论。
研究设计与样本
- 原文未报告研究设计与样本量。
主要发现
- 原文未报告本研究的具体数值结果。
关键数值与推荐
- 低正常甲状腺功能定义为促甲状腺激素水平在甲状腺功能正常参考范围内处于较高水平。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The pathogenetic pathways leading to increasing prevalence of advanced fibrosis in the setting of nonalcoholic fatty liver disease (NAFLD) and resulting in higher rates of liver-related and cardiovascular morbidity and mortality in the United States are multifactorial.1 The negative health impact of "low-normal" thyroid function, which is defined as a higher level of thyroid-stimulating hormone (TSH) within the euthyroid reference range, may be comparable with overt and subclinical hypothyroidism.2-4 We reported a strong association between biopsy-proven advanced fibrosis in NAFLD with increasing TSH levels in a dose-dependent manner even within the euthyroid reference range.5 To generalize our findings across all ethnicities, we examined the association of both low-normal thyroid function and subclinical hypothyroidism with advanced fibrosis in the US general population.
引用
- Kim D, Yoo ER, Li AA, et al. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2018. PMID: 30458247. doi:10.1016/j.cgh.2018.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。